Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Resistance Mechanisms to SYK Inhibition in AML

Anjali Cremer, MD, Jana M Ellegast, MD, Yana Pikman, MD, Gabriela Alexe, PhD, Linda Ross, PhD, Amy Goodale, Federica Piccioni, PhD, Elizabeth S Frank, Thomas Oellerich, MD, Kimberly Stegmaier, MD

Blood (2018) 132 (Supplement 1): 2638.

https://doi.org/10.1182/blood-2018-99-114996

Published: 2018

Journal Articles

Identification of a First in Class GSK3-Alpha Selective Inhibitor As a New Differentiation Therapy for AML

Lina Benajiba, Florence Wagner, PhD, Linda Ross, PhD, Ilene Galinsky, ANP, Daniel J. DeAngelo, MD PhD, Jennifer Gale, Jen Pan, PhD, Yan-Lin Zhang, PhD, Joshua Sacher, PhD, Michel Weiwer, PhD, Richard M. Stone, MD, Edward Holson, PhD, Kimberly Stegmaier, MD

Blood (2015) 126 (23): 870.

https://doi.org/10.1182/blood.V126.23.870.870

Published: 2015

Journal Articles

Targeting MTHFD2 in Acute Myeloid Leukemia

Yana Pikman, MD, Alexandre Puissant, PhD, Gabriela Alexe, PhD, Andrew Furman, BA, Stacey Frumm, BA, Linda Ross, PhD, Liying Chen, PhD, Nina Fenouille, PhD, Christopher F. Bassil, BA, Caroline A Lewis, PhD, Richard M. Stone, MD, Daniel J. DeAngelo, MD PhD, Ilene Galinsky, ANP, Andrew L Kung, MD PhD, Matthew Vader Heiden, MD PhD, Michael T. Hemann, PhD, Versha Banerji, MD, Kimberly Stegmaier, MD

Blood (2015) 126 (23): 443.

https://doi.org/10.1182/blood.V126.23.443.443

Published: 2015

Journal Articles

Targeting Folate Metabolism In Acute Myelogenous Leukemia

Yana Pikman, MD, Alexandre Puissant, PhD, Gabriela Alexe, PhD, Stacey M. Frumm, Linda Ross, PhD, Liying Chen, Ph.D., Nina Fenouille, PhD, Christopher F Bassil, Clary B. Clish, PhD, Andrew L Kung, MD, PhD, Michael T Hemann, PhD, Versha Banerji, MD, Kimberly Stegmaier, MD

Blood (2013) 122 (21): 3798.

https://doi.org/10.1182/blood.V122.21.3798.3798

Published: 2013

Journal Articles

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Versha Banerji, MD, Kenneth N. Ross, PhD, Loretta S. Li, MD, Stacey M. Frumm, Anna C. Schinzel, PhD, Cynthia K. Hahn, Rose M. Kakoza, MD, Kwan T. Chow, Linda Ross, PhD, Haig Inguilizian, MD, Ilene Galinsky, ANP, Richard M Stone, MD, Daniel J DeAngelo, MD, PhD, William C. Hahn, MD, PhD, Andrew L. Kung, MD, PhD, Kimberly Stegmaier, MD

Blood (2010) 116 (21): 1000.

https://doi.org/10.1182/blood.V116.21.1000.1000

Published: 2010

NARROW

Resistance Mechanisms to SYK Inhibition in AML

Identification of a First in Class GSK3-Alpha Selective Inhibitor As a New Differentiation Therapy for AML

Targeting MTHFD2 in Acute Myeloid Leukemia

Targeting Folate Metabolism In Acute Myelogenous Leukemia

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Resistance Mechanisms to SYK Inhibition in AML

Identification of a First in Class GSK3-Alpha Selective Inhibitor As a New Differentiation Therapy for AML

Targeting MTHFD2 in Acute Myeloid Leukemia

Targeting Folate Metabolism In Acute Myelogenous Leukemia

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only